Viewing Study NCT06023368



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06023368
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-03-18
First Post: 2023-08-28

Brief Title: Reducing Port Access Pain and Clinic Wait Time An Evaluation of EMLA Cream Versus nüm Vapocoolant Spray
Sponsor: Marianne Hutti
Organization: University of Kentucky

Study Overview

Official Title: Reducing Port Access Pain and Clinic Wait Time An Evaluation of EMLA Cream Versus nüm Vapocoolant Spray
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports

Participants will receive either the spray or cream prior to port access and rate pain on a scale

Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None